These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20692471)

  • 1. Small difference in international normalized ratio may yield a significant impact on prioritizing patients listed for liver transplantation.
    Sarvary E; Seregely Z; Fazakas J; Kovacs F; Gaal I; Beko G; Varga J; Kobori L; Nemes B; Gorog D; Varga M; Langer RM; Monostory K; Jaray J; Gerlei Z
    Transplant Proc; 2010; 42(6):2317-22. PubMed ID: 20692471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interlaboratory variability in assessment of the model of end-stage liver disease score.
    Lisman T; van Leeuwen Y; Adelmeijer J; Pereboom IT; Haagsma EB; van den Berg AP; Porte RJ
    Liver Int; 2008 Dec; 28(10):1344-51. PubMed ID: 18482269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation.
    Trotter JF; Brimhall B; Arjal R; Phillips C
    Liver Transpl; 2004 Aug; 10(8):995-1000. PubMed ID: 15390325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does model for end-stage liver disease (MELD) require modification?
    Desai HG
    J Assoc Physicians India; 2011 Jun; 59():372-3. PubMed ID: 21751591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MELD score as a prognostic model for listing acute liver failure patients for liver transplantation.
    Zaman MB; Hoti E; Qasim A; Maguire D; McCormick PA; Hegarty JE; Geoghegan JG; Traynor O
    Transplant Proc; 2006 Sep; 38(7):2097-8. PubMed ID: 16980011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area.
    Xiol X; Gines P; Castells L; Twose J; Ribalta A; Fuentes-Arderiu X; Rodriguez S; Castellote J; Navasa M; Deulofeu R
    Liver Transpl; 2009 Mar; 15(3):300-5. PubMed ID: 19242993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy.
    Heuman DM; Mihas AA; Habib A; Gilles HS; Stravitz RT; Sanyal AJ; Fisher RA
    Liver Transpl; 2007 Jan; 13(1):30-7. PubMed ID: 17154400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELD score and blood product requirements during liver transplantation: no link.
    Massicotte L; Beaulieu D; Roy JD; Marleau D; Vandenbroucke F; Dagenais M; Lapointe R; Roy A
    Transplantation; 2009 Jun; 87(11):1689-94. PubMed ID: 19502961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.
    Gheorghe L; Popescu I; Iacob R; Iacob S; Gheorghe C
    Transpl Int; 2005 May; 18(5):572-6. PubMed ID: 15819806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
    Piscaglia F; Camaggi V; Ravaioli M; Grazi GL; Zanello M; Leoni S; Ballardini G; Cavrini G; Pinna AD; Bolondi L
    Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of MELD score during the year before liver transplantation.
    Oton-Nieto E; Barcena-Marugan R; Carrera-Alonso E; Blesa-Radigales C; Garcia-Gonzalez M; Nuño J; Plaza-Palacios G; Garcia-Plaza A
    Transplant Proc; 2005 Nov; 37(9):3887-8. PubMed ID: 16386573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth.
    Schouten JN; Francque S; Van Vlierberghe H; Colle I; Nevens F; Delwaide J; Adler M; Starkel P; Ysebaert D; Gadisseur A; De Winter B; Smits JM; Rahmel A; Michielsen P
    Clin Transplant; 2012; 26(1):E62-70. PubMed ID: 22032173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MELD [corrected] score in patients accepted for liver transplantation 1994 to 2004.
    Flodén A; Castedal M; Friman S; Olausson M; Backman L
    Transplant Proc; 2006 Oct; 38(8):2673-4. PubMed ID: 17098035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive parameters after molecular absorbent recirculating system treatment integrated with model for end stage liver disease model in patients with acute-on-chronic liver failure.
    Novelli G; Rossi M; Ferretti G; Pugliese F; Travaglia D; Guidi S; Novelli S; Lai Q; Morabito V; Berloco PB
    Transplant Proc; 2010 May; 42(4):1182-7. PubMed ID: 20534256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.